FHTX EBITDA Growth
Foghorn Therapeutics Inc · EBITDA Growth
FHTX EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported13.52%period ending
FHTX TTM EBITDA YoY % (-59.77% → 13.52%)
Year-over-year change
High-resolution chart · PNG
FHTX ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| 13.522% | |
| 7.6354% | |
| 16.2869% | |
| 21.1386% | |
| 11.5294% | |
| 8.4788% | |
| 6.605% | |
| 10.4985% | |
| 25.5848% | |
| 20.8851% | |
| 14.0317% | |
| 7.5036% | |
| -4.2557% | |
| -7.9205% | |
| -9.0315% | |
| -18.7489% | |
| -28.3627% | |
| -33.3484% | |
| -45.6026% | |
| -44.3619% | |
| -45.344% | |
| -43.9646% | |
| -32.4634% | |
| -47.4358% | |
| -59.7666% |